Healthcare and Pharma

SGK receivables, stock expiry and price regulation for hospital groups and pharmaceutical and medical device distributors.

In healthcare a large part of revenue comes from public payers; collection delays and price regulation directly affect the financial statements. Expiry dates on drug and medical device stock also create valuation risk.

Audit focus

  • Collectability of SGK and private insurance receivables and deduction provisions
  • Recognition of service revenue and reconciliation to patient-level records
  • Expiry and impairment of drug and consumable stock
  • Medical device investments, leases and depreciation
  • Effects of price regulation

Our experience

Private hospitals, medical centres, pharmaceutical warehouses and medical device distributors.

Main audit risks

  • Public receivables
  • Stock expiry
  • Price regulation

Services we provide

  • Independent audit
  • Receivables ageing analysis
  • Transfer pricing

Similar items

Technology and Software

Revenue recognition, capitalisation of development costs and R&D incentives for SaaS, gaming, fintech and software companies.

Audited entities
19 organizations
Sector team
5 experts
Responsible partner
Pınar Kılıçoğlu

View all — Sector Expertise

WhatsApp +90 212 276 48 30 info@sahihdenetim.com.tr